Crescent Biopharma Revenue

Biotechnology Research • 300 5th Ave, Waltham, United States • 21-50 Employees

Crescent Biopharma revenue & valuation

Annual revenue	$3,593,310
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,500,000
Total funding	$400,000,000

Key Contacts at Crescent Biopharma

Matt Drapeau

Senior Director, Contracts

Jonathan Violin

Member, Board Of Directors

Lee Schwartz

Sr. Director, Human Resources

Jacquelynn Lucas

Sr. Director Toxicology

Emily Putiri

Senior Director, Clinical Science

Susan Moran

Member Board Of Directors

Mary-Kathryn Canning

Executive Director, Program Management

Min Lu

Executive Director, Translational Medicine

Matt Grenier

Director, Corporate Controller

Lindsay Buckley

Senior Director, Medical Writing

Company overview

Headquarters	300 5th Ave, Waltham, Massachusetts 02451, US
Website	crescentbiopharma.com
NAICS	541714
Employees	21-50
Socials

Crescent Biopharma Email Formats

Crescent Biopharma uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@crescentbiopharma.com), used 50% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@crescentbiopharma.com	50%
{first initial}.{last name}	j.doe@crescentbiopharma.com	46.4%
{first initial}.{f2}{f3}	j.{f2}{f3}@crescentbiopharma.com	3.6%

About Crescent Biopharma

Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. Crescent’s pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

C-Suite

Vice President

Employees by Department

Crescent Biopharma has 21 employees across 10 departments.

Departments

Number of employees

Funding Data

Explore Crescent Biopharma's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-11-29	15	$200,000,000
2025-07-16	14	$200,000,000

Funding Insights

$400,000,000

Total funding amount

$200,000,000

Most recent funding amount

Number of funding rounds

Crescent Biopharma Tech Stack

Discover the technologies and tools that power Crescent Biopharma's digital infrastructure, from frameworks to analytics platforms.

Adobe Fonts

Font scripts

Google Tag Manager

Tag managers

GoDaddy

Hosting

HSTS

Security

Open Graph

Miscellaneous

React

JavaScript frameworks

PWA

Miscellaneous

Google Analytics

Analytics

Netlify

CDN

Gatsby

JavaScript frameworks

Webpack

Miscellaneous

Microsoft 365

Frequently asked questions

Crescent Biopharma is located in 300 5th Ave, Waltham, US.

Crescent Biopharma generates an estimated annual revenue of $3,593,310. This revenue figure reflects the company's market position and business performance in its industry.

Crescent Biopharma has an estimated valuation of $11,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Crescent Biopharma has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Crescent Biopharma has raised a total of $400,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Crescent Biopharma

Matt Drapeau

Senior Director, Contracts

Jonathan Violin

Member, Board Of Directors

Lee Schwartz

Sr. Director, Human Resources

Jacquelynn Lucas

Sr. Director Toxicology

Emily Putiri

Senior Director, Clinical Science

Susan Moran